Hypertension
Conditions
Keywords
observational, blood pressure, SBP, DBP, hypertension, HBP, HTA, Viacoram®, Perindopril arginine and Amlodipine, patient educational program
Brief summary
The primary objective is to assess the change of systolic blood pressure from baseline after a 6-month follow up for hypertensive patients initiating Viacoram® plus an educational program (NGAYDAUTIEN) in comparison to hypertensive patients initiating other antihypertensive drugs (except single pill combination).
Interventions
None listed
Sponsors
Study design
Eligibility
Inclusion criteria
1. Aged of at least 18 years (without upper limit of age) 2. Diagnosis of grade 1 or grade 2 hypertension 3. Naïve of treatment: * newly diagnosed hypertension and without treatment with antihypertensive effect for at least 3 months * previously diagnosed but without treatment with antihypertensive effect for at least 3 months 4. Patients follow-up within the scope of the current medical practice and in the same health centre during the 6-month period
Exclusion criteria
1. Previously attended to the Ngay Dau Tien educational program for HBP management 2. Plan to be hospitalized for other medical conditions during the next 6 months 3. Plan to move/relocate during 6-month follow-up 4. Have a severe disease (i.e. cirrhosis, end-stage renal disease …) 5. Are unlikely to cooperate in the study 6. Arm 1: patient having contra-indication to take Viacoram® according to SmPC 7. Arm 2: patient showing interest in attending NDT educational program.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| change of systolic blood pressure (measured in mmHg) from baseline after a 6-month follow up among the 2 arms | from baseline to 6-month follow-up |
Countries
France